David J. Stewart – författare

Like other groups with dangerous occupations, mariners have developed a close-knit culture bound by loss and memory. Death regularly disrupts the fabric of this culture and necessitates actions designed to mend its social structure. From the ritual of burying a body at sea to the creation of memorials to honor the missing, these events tell us a great deal about how sailors see their world. Based on a study of more than 2,100 gravestones and monuments in North America and the United Kingdom erected between the seventeenth and late twentieth centuries, David Stewart expands the use of nautical archaeology into terrestrial environments. He focuses on those who make their living at sea--one of the world''s oldest and most dangerous occupations--to examine their distinct folkloric traditions, beliefs, and customs regarding death, loss, and remembrance.

Like other groups with dangerous occupations, mariners have developed a close-knit culture bound by loss and memory. Death regularly disrupts the fabric of this culture and necessitates actions designed to mend its social structure. From the ritual of burying a body at sea to the creation of memorials to honor the missing, these events tell us a great deal about how sailors see their world. Based on a study of more than 2,100 gravestones and monuments in North America and the United Kingdom erected between the seventeenth and late twentieth centuries, David Stewart expands the use of nautical archaeology into terrestrial environments. He focuses on those who make their living at sea--one of the world's oldest and most dangerous occupations--to examine their distinct folkloric traditions, beliefs, and customs regarding death, loss, and remembrance. A volume in the series New Perspectives on Maritime History and Nautical Archaeology, edited by James C. Bradford and Gene Allen Smith.

Defining the Lung Cancer Problem 1 Lung cancer is the leading cause of cancer death in the world. It kills almost as many Americans as cancers of the breast, prostate, colon, rectum, pancreas, and 2 kidney combined, and accounts for 28.6% of all US cancer deaths. With an increase in the 5-year relative survival rate from 13% to only 16% in the more than 2 30 years from 1974 to the present, it will take us another 840 years to eradicate lung cancer deaths if we do not improve the current rate of progress. As discussed in this text, lung cancer prevention has received substantial att- tion. The decrease in smoking in recent decades has helped, but smoking is not the only problem. Lung cancer in people who have never smoked is currently the 5th 3 leading cause of cancer death in the United States. Several factors contribute to the lethality of lung cancer, including the rapidity of tumor growth, advanced stage at diagnosis (due to nonspecificity of early sy- toms and the uncertain efficacy of screening), early development of metastases, and resistance to therapy. Several chapters in this book discuss new molecular targets that may be potentially exploitable in the future, as well as discussing our track record to date in exploiting them.

Defining the Lung Cancer Problem 1 Lung cancer is the leading cause of cancer death in the world. It kills almost as many Americans as cancers of the breast, prostate, colon, rectum, pancreas, and 2 kidney combined, and accounts for 28.6% of all US cancer deaths. With an increase in the 5-year relative survival rate from 13% to only 16% in the more than 2 30 years from 1974 to the present, it will take us another 840 years to eradicate lung cancer deaths if we do not improve the current rate of progress. As discussed in this text, lung cancer prevention has received substantial att- tion. The decrease in smoking in recent decades has helped, but smoking is not the only problem. Lung cancer in people who have never smoked is currently the 5th 3 leading cause of cancer death in the United States. Several factors contribute to the lethality of lung cancer, including the rapidity of tumor growth, advanced stage at diagnosis (due to nonspecificity of early sy- toms and the uncertain efficacy of screening), early development of metastases, and resistance to therapy. Several chapters in this book discuss new molecular targets that may be potentially exploitable in the future, as well as discussing our track record to date in exploiting them.